Acurx Pharmaceuticals reported Q3 2026 results highlighting progress in its lead antibiotic candidate, ibezapolstat, aimed at treating acute and recurrent C. difficile infections (CDI). The company began enrolling patients in the PATHFINDER trial for recurrent CDI and received FDA guidance supporting a single Phase 3 pivotal trial for acute CDI. Ibezapolstat shows promising efficacy and microbiome-sparing benefits, with recent patents granted in Japan and Mexico strengthening its intellectual property. With $9.7 million cash on hand and ongoing trials, Acurx is positioned to advance toward regulatory approval and commercialization.
Acurx Pharmaceuticals Q3 2026 results provide context for readers. Of 150 priced Health-sector US stocks on Pluang, 84 rose and 57 fell today. Maravai LifeSciences Holdings Inc. Class A (MRVI) rose 2.99% to USD 7.93 with a typical hold time of 18 days and 55% sell activity. Eli Lilly And Co (LLY) increased 2.66% to USD 1,476.03 with a 94-day hold time and 83% sell orders. Definium Therapeutics Inc. (DFTX) declined 2.61% to USD 33.57 with an 18-day hold time and 100% sell activity. Data as of Nov 12, 2026 18:11 WIB.
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....
Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...
Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...
A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...
